Structure of C3b reveals conformational changes that underlie complement activity

被引:290
作者
Janssen, Bert J. C.
Christodoulidou, Agni
McCarthy, Andrew
Lambris, John D.
Gros, Piet
机构
[1] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature05172
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Resistance to infection and clearance of cell debris in mammals depend on the activation of the complement system, which is an important component of innate and adaptive immunity(1,2). Central to the complement system is the activated form of C3, called C3b, which attaches covalently to target surfaces(3) to amplify complement response, label cells for phagocytosis and stimulate the adaptive immune response. C3b consists of 1,560 amino-acid residues and has 12 domains. It binds various proteins and receptors to effect its functions(4). However, it is not known how C3 changes its conformation into C3b and thereby exposes its many binding sites. Here we present the crystal structure at 4-angstrom resolution of the activated complement protein C3b and describe the conformational rearrangements of the 12 domains that take place upon proteolytic activation. In the activated form the thioester is fully exposed for covalent attachment to target surfaces and is more than 85 angstrom away from the buried site in native C3 (ref. 5). Marked domain rearrangements in the alpha-chain present an altered molecular surface, exposing hidden and cryptic sites that are consistent with known putative binding sites of factor B and several complement regulators. The structural data indicate that the large conformational changes in the proteolytic activation and regulation of C3 take place mainly in the first conversion step, from C3 to C3b. These insights are important for the development of strategies to treat immune disorders that involve complement-mediated inflammation.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 30 条
[1]  
[Anonymous], ACTA CRYSTALLOGR D
[2]   Influence of donor C3 allotype on late renal-transplantation outcome [J].
Brown, KM ;
Kondeatis, E ;
Vaughan, RW ;
Kon, SP ;
Farmer, CKT ;
Taylor, JD ;
He, X ;
Johnston, A ;
Horsfield, C ;
Janssen, BJC ;
Gros, P ;
Zhou, WD ;
Sacks, SH ;
Sheerin, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (19) :2014-2023
[3]   The complement system in regulation of adaptive immunity [J].
Carroll, MC .
NATURE IMMUNOLOGY, 2004, 5 (10) :981-986
[4]   Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21) [J].
Clemenza, L ;
Isenman, DE .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3839-3848
[5]  
DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577
[6]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350
[7]   The reaction mechanism of the internal thioester in the human complement component C4 [J].
Dodds, AW ;
Ren, XD ;
Willis, AC ;
Law, SKA .
NATURE, 1996, 379 (6561) :177-179
[8]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[9]  
FISHELSON Z, 1984, J IMMUNOL, V132, P1430
[10]   NOVEL CLEAVAGE PRODUCTS OF THE 3RD COMPONENT OF HUMAN-COMPLEMENT [J].
HARRISON, RA ;
LACHMANN, PJ .
MOLECULAR IMMUNOLOGY, 1980, 17 (02) :219-228